Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1992 Apr;140(4):859–870.

Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.

H Imai 1, R L Ochs 1, K Kiyosawa 1, S Furuta 1, R M Nakamura 1, E M Tan 1
PMCID: PMC1886358  PMID: 1314027

Abstract

Patients with hepatocellular carcinoma (HCC), gastrointestinal, lung, and ovarian cancers were shown to have autoantibodies to nuclear and nucleolar antigens as detected by immunofluorescence on cell substrates. The frequency of antinuclear antibodies (ANAs) was significantly higher (P less than 0.001) in patients with HCC (57/184 = 31%) than in patients with chronic hepatitis or liver cirrhosis (25/187 = 13%). Although a range of fluorescence patterns was observed, a higher percentage of nucleolar fluorescence was detected in HCC, and three of these nucleolar antigens were identified. They were NOR-90, nucleolus organizer region doublet polypeptides of 93 and 89 kDa involved in RNA polymerase I transcription; fibrillarin, a 34 kDa protein of the nucleolar U3 ribonucleoprotein particle which is engaged in preribosomal RNA processing; and nucleophosmin/protein B23, a 37 kDa polypeptide which is associated with ribosome maturation and cellular proliferation. All these antigens are nucleolar components that are engaged in some aspect of ribosome biosynthesis. Since autoantibodies to these nucleolar antigens have also been found in systemic autoimmune diseases, they do not represent autoimmune reactions unique to cancer but might reflect reaction pathways related to immune responses that are antigen-driven. The ANA response in HCC appears to be dynamic reactions to this antigen-drive since some patients with chronic liver disease showed seroconversion to ANA positivity, marked increase in titer and/or change in antibody specificity preceding or coincident with clinical detection of HCC. These changes in ANA showed a close temporal relationship with transformation from long-established chronic liver disease to HCC.

Full text

PDF
859

Images in this article

862Figure 1
on p.862
863Figure 2
on p.863
864Figure 3
on p.864
864Figure 4
on p.864
865Figure 5
on p.865
866Figure 6
on p.866
867Figure 7
on p.867
868Figure 9
on p.868

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablin R. J. Malignancy associated with antinuclear antibodies. Lancet. 1972 Dec 9;2(7789):1253–1254. doi: 10.1016/s0140-6736(72)92308-2. [DOI] [PubMed] [Google Scholar]
  2. Bonfa E., Bystryn J. C., Elkon K. B. Detection of immunoglobulin G antibodies in melanoma sera reactive with intracellular proteins. J Invest Dermatol. 1988 Feb;90(2):207–212. doi: 10.1111/1523-1747.ep12462233. [DOI] [PubMed] [Google Scholar]
  3. Budde-Steffen C., Anderson N. E., Rosenblum M. K., Posner J. B. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy. Cancer Res. 1988 Jan 15;48(2):430–434. [PubMed] [Google Scholar]
  4. Burke B., Griffiths G., Reggio H., Louvard D., Warren G. A monoclonal antibody against a 135-K Golgi membrane protein. EMBO J. 1982;1(12):1621–1628. doi: 10.1002/j.1460-2075.1982.tb01364.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burnham T. K. Antinuclear antibodies in patients with malignancies. Lancet. 1972 Aug 26;2(7774):436–436. doi: 10.1016/s0140-6736(72)91842-9. [DOI] [PubMed] [Google Scholar]
  6. Chan E. K., Imai H., Hamel J. C., Tan E. M. Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med. 1991 Nov 1;174(5):1239–1244. doi: 10.1084/jem.174.5.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen Y. M., Hu C. P., Chen P. H., Chu M. H., Tsai Y. T., Lee S. D., Chang C. M. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients. Hepatology. 1988 May-Jun;8(3):547–552. doi: 10.1002/hep.1840080319. [DOI] [PubMed] [Google Scholar]
  8. Fathallah-Shaykh H., Wolf S., Wong E., Posner J. B., Furneaux H. M. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3451–3454. doi: 10.1073/pnas.88.8.3451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Feuerstein N., Chan P. K., Mond J. J. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem. 1988 Aug 5;263(22):10608–10612. [PubMed] [Google Scholar]
  10. Goodpasture C., Bloom S. E. Visualization of nucleolar organizer regions im mammalian chromosomes using silver staining. Chromosoma. 1975 Nov 20;53(1):37–50. doi: 10.1007/BF00329389. [DOI] [PubMed] [Google Scholar]
  11. Hodson M. E., Turner-Warwick M. Autoantibodies in patients with bronchial carcinoma. Thorax. 1975 Aug;30(4):367–370. doi: 10.1136/thx.30.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jantzen H. M., Admon A., Bell S. P., Tjian R. Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins. Nature. 1990 Apr 26;344(6269):830–836. doi: 10.1038/344830a0. [DOI] [PubMed] [Google Scholar]
  13. Kass S., Tyc K., Steitz J. A., Sollner-Webb B. The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing. Cell. 1990 Mar 23;60(6):897–908. doi: 10.1016/0092-8674(90)90338-f. [DOI] [PubMed] [Google Scholar]
  14. Kekulé A. S., Lauer U., Meyer M., Caselmann W. H., Hofschneider P. H., Koshy R. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature. 1990 Feb 1;343(6257):457–461. doi: 10.1038/343457a0. [DOI] [PubMed] [Google Scholar]
  15. Kindås-Mügge I. Human autoantibodies against a nucleolar protein. Biochem Biophys Res Commun. 1989 Sep 15;163(2):1119–1127. doi: 10.1016/0006-291x(89)92337-1. [DOI] [PubMed] [Google Scholar]
  16. Kiyosawa K., Daemer R. J., He L. F., Bonino F., Prozesky O. W., Purcell R. H. The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma. Hepatology. 1985 Jul-Aug;5(4):548–555. doi: 10.1002/hep.1840050405. [DOI] [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Lamelin J. P., de-The G., Revillard J. P., Gabbiani G. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients. IARC Sci Publ. 1978;(20):523–536. [PubMed] [Google Scholar]
  19. Li X. Z., McNeilage L. J., Whittingham S. Autoantibodies to the major nucleolar phosphoprotein B23 define a novel subset of patients with anticardiolipin antibodies. Arthritis Rheum. 1989 Sep;32(9):1165–1169. doi: 10.1002/anr.1780320917. [DOI] [PubMed] [Google Scholar]
  20. Lischwe M. A., Ochs R. L., Reddy R., Cook R. G., Yeoman L. C., Tan E. M., Reichlin M., Busch H. Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem. 1985 Nov 15;260(26):14304–14310. [PubMed] [Google Scholar]
  21. Matsubara K., Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med. 1990 Jun;7(3):243–260. [PubMed] [Google Scholar]
  22. Merry D. E., Pathak S., Hsu T. C., Brinkley B. R. Anti-kinetochore antibodies: use as probes for inactive centromeres. Am J Hum Genet. 1985 Mar;37(2):425–430. [PMC free article] [PubMed] [Google Scholar]
  23. Nelson D. S. Autoantibodies in cancer patients. Pathology. 1977 Apr;9(2):155–160. doi: 10.3109/00313027709085253. [DOI] [PubMed] [Google Scholar]
  24. O'Farrell P. Z., Goodman H. M., O'Farrell P. H. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell. 1977 Dec;12(4):1133–1141. doi: 10.1016/0092-8674(77)90176-3. [DOI] [PubMed] [Google Scholar]
  25. Ochs R. L., Lischwe M. A., Spohn W. H., Busch H. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell. 1985;54(2):123–133. doi: 10.1111/j.1768-322x.1985.tb00387.x. [DOI] [PubMed] [Google Scholar]
  26. Ochs R., Lischwe M., O'Leary P., Busch H. Localization of nucleolar phosphoproteins B23 and C23 during mitosis. Exp Cell Res. 1983 Jun;146(1):139–149. doi: 10.1016/0014-4827(83)90332-4. [DOI] [PubMed] [Google Scholar]
  27. Okuda K., Fujimoto I., Hanai A., Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987 Sep 15;47(18):4967–4972. [PubMed] [Google Scholar]
  28. Pfeifle J., Anderer F. A., Franke M. Characterisation of nucleolar proteins as autoantigens using human autoimmune sera. Ann Rheum Dis. 1986 Dec;45(12):978–986. doi: 10.1136/ard.45.12.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Phillips S. G., Phillips D. M. Nucleoli of diploid cell strains. Thei normal ultrastructure and the effects of toyocamycin and actinomycin D. J Cell Biol. 1971 Jun;49(3):785–802. doi: 10.1083/jcb.49.3.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., Adnet J. J. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J. 1986 Jan;18(1):5–14. doi: 10.1007/BF01676192. [DOI] [PubMed] [Google Scholar]
  31. Polans A. S., Buczyłko J., Crabb J., Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol. 1991 Mar;112(5):981–989. doi: 10.1083/jcb.112.5.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Popper H., Shafritz D. A., Hoofnagle J. H. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology. 1987 Jul-Aug;7(4):764–772. doi: 10.1002/hep.1840070425. [DOI] [PubMed] [Google Scholar]
  33. Prestayko A. W., Klomp G. R., Schmoll D. J., Busch H. Comparison of proteins of ribosomal subunits and nucleolar preribosomal particles from Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis. Biochemistry. 1974 Apr 23;13(9):1945–1951. doi: 10.1021/bi00706a026. [DOI] [PubMed] [Google Scholar]
  34. Reimer G., Pollard K. M., Penning C. A., Ochs R. L., Lischwe M. A., Busch H., Tan E. M. Monoclonal autoantibody from a (New Zealand black x New Zealand white)F1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle. Arthritis Rheum. 1987 Jul;30(7):793–800. doi: 10.1002/art.1780300709. [DOI] [PubMed] [Google Scholar]
  35. Reimer G., Steen V. D., Penning C. A., Medsger T. A., Jr, Tan E. M. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1988 Apr;31(4):525–532. doi: 10.1002/art.1780310409. [DOI] [PubMed] [Google Scholar]
  36. Rodriguez-Sanchez J. L., Gelpi C., Juarez C., Hardin J. A. Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. J Immunol. 1987 Oct 15;139(8):2579–2584. [PubMed] [Google Scholar]
  37. Sakai K., Mitchell D. J., Tsukamoto T., Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol. 1990 Nov;28(5):692–698. doi: 10.1002/ana.410280515. [DOI] [PubMed] [Google Scholar]
  38. Schattner A., Shani A., Talpaz M., Bentwich Z. Rheumatoid factors in the sera of patient with gastrointestinal carcinoma. Cancer. 1983 Dec 1;52(11):2156–2161. doi: 10.1002/1097-0142(19831201)52:11<2156::aid-cncr2820521130>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  39. Seiner M., Klein E., Klein G. Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases. Clin Immunol Immunopathol. 1975 Sep;4(3):374–381. doi: 10.1016/0090-1229(75)90006-9. [DOI] [PubMed] [Google Scholar]
  40. Slagle B. L., Zhou Y. Z., Butel J. S. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res. 1991 Jan 1;51(1):49–54. [PubMed] [Google Scholar]
  41. Spandau D. F., Lee C. H. trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol. 1988 Feb;62(2):427–434. doi: 10.1128/jvi.62.2.427-434.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Spector D. L., Ochs R. L., Busch H. Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23. Chromosoma. 1984;90(2):139–148. doi: 10.1007/BF00292451. [DOI] [PubMed] [Google Scholar]
  43. Tan E. M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989;44:93–151. doi: 10.1016/s0065-2776(08)60641-0. [DOI] [PubMed] [Google Scholar]
  44. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  45. Thomas P. J., Kaur J. S., Aitcheson C. T., Robinson W. A., Tan E. M. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma. Cancer Res. 1983 Mar;43(3):1372–1380. [PubMed] [Google Scholar]
  46. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature. 1985 Oct 10;317(6037):489–495. doi: 10.1038/317489a0. [DOI] [PubMed] [Google Scholar]
  47. Wasserman J., Glas U., Blomgren H. Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. Clin Exp Immunol. 1975 Mar;19(3):417–422. [PMC free article] [PubMed] [Google Scholar]
  48. Whitehouse J. M., Holborow E. J. Smooth muscle antibody in malignant disease. Br Med J. 1971 Nov 27;4(5786):511–513. doi: 10.1136/bmj.4.5786.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yung B. Y., Busch H., Chan P. K. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochim Biophys Acta. 1985 Dec 18;826(4):167–173. doi: 10.1016/0167-4781(85)90002-8. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES